Literature DB >> 23171822

The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.

P Zarb1, B Coignard, J Griskeviciene, A Muller, V Vankerckhoven, K Weist, Mm Goossens, S Vaerenberg, S Hopkins, B Catry, Dl Monnet, H Goossens, C Suetens.   

Abstract

A standardised methodology for a combined point prevalence survey (PPS) on healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals developed by the European Centre for Disease Prevention and Control was piloted across Europe. Variables were collected at national, hospital and patient level in 66 hospitals from 23 countries. A patient-based and a unit-based protocol were available. Feasibility was assessed via national and hospital questionnaires. Of 19,888 surveyed patients, 7.1% had an HAI and 34.6% were receiving at least one antimicrobial agent. Prevalence results were highest in intensive care units, with 28.1% patients with HAI, and 61.4% patients with antimicrobial use. Pneumonia and other lower respiratory tract infections (2.0% of patients; 95% confidence interval (CI): 1.8–2.2%) represented the most common type (25.7%) of HAI. Surgical prophylaxis was the indication for 17.3% of used antimicrobials and exceeded one day in 60.7% of cases. Risk factors in the patient-based protocol were provided for 98% or more of the included patients and all were independently associated with both presence of HAI and receiving an antimicrobial agent. The patient-based protocol required more work than the unit-based protocol, but allowed collecting detailed data and analysis of risk factors for HAI and antimicrobial use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23171822     DOI: 10.2807/ese.17.46.20316-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  134 in total

Review 1.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

2.  Antibiotic hospital consumption expressed in defined daily doses (DDD)/100 bed-days.

Authors:  M Cizman; B Beovic
Journal:  Infection       Date:  2014-02       Impact factor: 3.553

3.  Antimicrobial activity Study of triclosan-loaded WBPU on Proteus mirabilis in vitro.

Authors:  Ye Tian; Zhongyu Jian; Jianzhong Wang; Wei He; Qinyu Liu; Kunjie Wang; Hong Li; Hong Tan
Journal:  Int Urol Nephrol       Date:  2017-02-01       Impact factor: 2.370

4.  In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.

Authors:  Gregory G Stone; Patricia A Bradford; Margaret Tawadrous; Dianna Taylor; Mary Jane Cadatal; Zhangjing Chen; Joseph W Chow
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 5.  Antimicrobial resistance in hospital-acquired gram-negative bacterial infections.

Authors:  Borna Mehrad; Nina M Clark; George G Zhanel; Joseph P Lynch
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

Review 6.  Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review.

Authors:  Gabor S A Abis; Hein B A C Stockmann; Marjolein van Egmond; Hendrik J Bonjer; Christina M J E Vandenbroucke-Grauls; Steven J Oosterling
Journal:  J Gastrointest Surg       Date:  2013-10-11       Impact factor: 3.452

7.  Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China.

Authors:  Dazhi Jin; Yun Luo; Chen Huang; Jian Cai; Julian Ye; Yi Zheng; Liqian Wang; Peng Zhao; Anbing Liu; Weijia Fang; Xianjun Wang; Shichang Xia; Jianmin Jiang; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

8.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

9.  Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune.

Authors:  Velu Nair; Dinesh Sharma; A K Sahni; Naveen Grover; S Shankar; S S Jaiswal; S S Dalal; D R Basannar; Vivek S Phutane; Atul Kotwal; G Gopal Rao; Deepak Batura; M D Venkatesh; Tapan Sinha; Sushil Kumar; D P Joshi
Journal:  Med J Armed Forces India       Date:  2015-02-25

10.  Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.

Authors:  Judith Maria Wenisch; Susanne Equiluz-Bruck; Marta Fudel; Ingun Reiter; Andrea Schmid; Erna Singer; Andreas Chott
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.